SETTING: Central Rio de Janeiro, Brazil. OBJECTIVE: To compare the impact of routine DOTS vs. enhanced DOTS (DOTS-Ampliado or DOTS-A) on tuberculosis (TB) incidence. DESIGN: Cluster-randomized trial in eight urban neighborhoods pair-matched by TB incidence and randomly assigned to receive either the DOTS-A or DOTS strategy. DOTS-A added intensive screening of household contacts of active TB cases and provision of treatment to secondary cases and preventive therapy to contacts with latent TB infection (LTBI) to the standard DOTS strategy. The primary endpoint was the TB incidence rates in communities after 5 years of intervention. RESULTS:From November 2000 to December 2004, respectively 339 and 311 pulmonary TB cases were enrolled and 1003 and 960 household were identified in DOTS and DOTS-A communities. Among contacts from DOTS-A communities, 26 (4%) had active TB diagnosed and treated, 429 (61.3%) had LTBI detected and 258 (60.1%) started preventive therapy. TB incidence increased by 5% in DOTS communities and decreased by 10% in DOTS-A communities, for a difference of 15% after 5 years (P = 0.04). CONCLUSION: DOTS-A was associated with a modest reduction in TB incidence and may be an important strategy for reducing the burden of TB.
RCT Entities:
SETTING: Central Rio de Janeiro, Brazil. OBJECTIVE: To compare the impact of routine DOTS vs. enhanced DOTS (DOTS-Ampliado or DOTS-A) on tuberculosis (TB) incidence. DESIGN: Cluster-randomized trial in eight urban neighborhoods pair-matched by TB incidence and randomly assigned to receive either the DOTS-A or DOTS strategy. DOTS-A added intensive screening of household contacts of active TB cases and provision of treatment to secondary cases and preventive therapy to contacts with latent TB infection (LTBI) to the standard DOTS strategy. The primary endpoint was the TB incidence rates in communities after 5 years of intervention. RESULTS: From November 2000 to December 2004, respectively 339 and 311 pulmonary TB cases were enrolled and 1003 and 960 household were identified in DOTS and DOTS-A communities. Among contacts from DOTS-A communities, 26 (4%) had active TB diagnosed and treated, 429 (61.3%) had LTBI detected and 258 (60.1%) started preventive therapy. TB incidence increased by 5% in DOTS communities and decreased by 10% in DOTS-A communities, for a difference of 15% after 5 years (P = 0.04). CONCLUSION: DOTS-A was associated with a modest reduction in TB incidence and may be an important strategy for reducing the burden of TB.
Authors: P G Suárez; C J Watt; E Alarcón; J Portocarrero; D Zavala; R Canales; F Luelmo; M A Espinal; C Dye Journal: J Infect Dis Date: 2001-07-18 Impact factor: 5.226
Authors: A C Carvalho; K DeRiemer; Z B Nunes; M Martins; M Comelli; A Marinoni; A L Kritski Journal: Am J Respir Crit Care Med Date: 2001-12-15 Impact factor: 21.405
Authors: M Cailleaux-Cezar; D de A Melo; G M Xavier; C L G de Salles; F C Q de Mello; A Ruffino-Netto; J E Golub; A Efron; R E Chaisson; M B Conde Journal: Int J Tuberc Lung Dis Date: 2009-02 Impact factor: 2.373
Authors: S E Weis; P C Slocum; F X Blais; B King; M Nunn; G B Matney; E Gomez; B H Foresman Journal: N Engl J Med Date: 1994-04-28 Impact factor: 91.245
Authors: D Guwatudde; M Nakakeeto; E C Jones-Lopez; A Maganda; A Chiunda; R D Mugerwa; J J Ellner; G Bukenya; C C Whalen Journal: Am J Epidemiol Date: 2003-11-01 Impact factor: 4.897
Authors: Molebogeng X Rangaka; Solange C Cavalcante; Ben J Marais; Sok Thim; Neil A Martinson; Soumya Swaminathan; Richard E Chaisson Journal: Lancet Date: 2015-10-26 Impact factor: 79.321
Authors: E L N Maciel; W Pan; R Dietze; R L Peres; S A Vinhas; F K Ribeiro; M Palaci; R R Rodrigues; E Zandonade; J E Golub Journal: Int J Tuberc Lung Dis Date: 2010-11 Impact factor: 2.373
Authors: Julia Moreira Pescarini; Laura Cunha Rodrigues; M Gabriela M Gomes; Eliseu Alves Waldman Journal: Global Health Date: 2017-03-15 Impact factor: 4.185
Authors: Shona Horter; Beverley Stringer; Lucy Reynolds; Muhammad Shoaib; Samuel Kasozi; Esther C Casas; Meggy Verputten; Philipp du Cros Journal: BMC Health Serv Res Date: 2014-02-21 Impact factor: 2.655
Authors: Lucie Blok; Jacob Creswell; Robert Stevens; Miranda Brouwer; Oriol Ramis; Olivier Weil; Paul Klatser; Suvanand Sahu; Mirjam I Bakker Journal: Int Health Date: 2014-08-06 Impact factor: 2.473
Authors: Sara C Auld; Anne G Kasmar; David W Dowdy; Barun Mathema; Neel R Gandhi; Gavin J Churchyard; Roxana Rustomjee; N Sarita Shah Journal: J Infect Dis Date: 2017-11-03 Impact factor: 5.226